Record
Loading…
Record
Loading…
organization
Amgen is an American multinational biopharmaceutical company, headquartered in Thousand Oaks. Its CEO is Robert A. Bradway, since . It reported revenue of $36.75B for the period ended .
| fact | value | valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About → | confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About → | sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About → |
|---|
No dated events on the record yet.
Every claim on the timeline, including undated ones →"sameAs": ["https://www.wikidata.org/wiki/Q470517", "https://asof.is/record/amgen"],
"identifier": { "@type": "PropertyValue", "propertyID": "asof", "value": "ent_amgen" }| Chair | Robert A. Bradway | sec.gov: 1 source for Chair, claim clm_3662BB7CA128 |
|---|---|---|
| quarterly net income | 3,864,000,000 United States dollar | sec.gov: 1 source for quarterly net income, claim clm_92C83000279C |
| quarterly operating income | 3,710,000,000 United States dollar | sec.gov: 1 source for quarterly operating income, claim clm_B7EB0BB6DBEB |
| quarterly revenue | sec.gov: 1 source for quarterly revenue, claim clm_985DF46177C9 | |
| shares outstanding | sec.gov: 1 source for shares outstanding, claim clm_E74CF4B58FED | |
| total equity | sec.gov: 1 source for total equity, claim clm_1845D943407A |
latest on record; no newer figure held